Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
View/ Open
Volume
2
Pagination
78 - 106
DOI
10.3390/v2010078
Journal
VIRUSES-BASEL
Issue
ISSN
1999-4915
Metadata
Show full item recordAuthors
Wong, HH; Lemoine, NR; Wang, YHCollections
Licence information
Copyright statements
Related items
Showing items related by title, author, creator and subject.
-
Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure
Salpini, R; D'Anna, S; Benedetti, L; Piermatteo, L; Gill, U; Svicher, V; Kennedy, PTF (2022) -
Establishing elements of a synthetic biology platform for Vaccinia virus production: BioBrick™ design, serum-free virus production and microcarrier-based cultivation of CV-1 cells.
Liu, S; Ruban, L; Wang, Y; Zhou, Y; Nesbeth, DN (2017-02)Vaccinia virus (VACV) is an established vector for vaccination and is beginning to prove effective as an oncolytic agent. Industrial production of VACV stands to benefit in future from advances made by synthetic biology ... -
Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer.
Howells, A; Marelli, G; Lemoine, NR; Wang, Y (2017)Oncolytic viruses (OVs) are an emerging treatment option for many cancer types and have recently been the focus of extensive research aiming to develop their therapeutic potential. The ultimate aim is to design a virus ...